The kinase inhibitor Sorafenib impairs the antiviral effect of interferon α on hepatitis C virus replication
- 31 January 2013
- journal article
- Published by Elsevier BV in European Journal of Cell Biology
- Vol. 92 (1), 12-20
- https://doi.org/10.1016/j.ejcb.2012.09.001
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Hepatitis C Virus Impairs the Induction of Cytoprotective Nrf2 Target Genes by Delocalization of Small Maf ProteinsJournal of Biological Chemistry, 2011
- Multi-pathway cellular analysis of compound selectivityMolecular BioSystems, 2010
- Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis CHepatology, 2009
- Sorafenib inhibits signal transducer and activator of transcription-3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2Hepatology, 2009
- Hepatitis C virus escape from the interferon regulatory factor 3 pathway by a passive and active evasion strategyHepatology, 2007
- SorafenibCurrent Opinion in Oncology, 2006
- Inhibition of dsRNA-induced signaling in hepatitis C virus-infected cells by NS3 protease-dependent and -independent mechanismsProceedings of the National Academy of Sciences, 2006
- Raf‐1 kinase associates with Hepatitis C virus NS5A and regulates viral replicationFEBS Letters, 2005
- Evidence That Hepatitis C Virus Resistance to Interferon Is Mediated through Repression of the PKR Protein Kinase by the Nonstructural 5A ProteinVirology, 1997
- Serum-, TPA-, and Ras-induced expression from Ap-1/Ets-driven promoters requires Raf-1 kinase.Genes & Development, 1992